PXL-330 Platinum device for crosslinking with Peschke riboflavin solution

COMBINATION_PRODUCT4 trials

Sponsors

Goodman Eye Center, Cornea Associates of Texas, Colorado Eye Consultants/Cornea Consultants of Colorado

Conditions

Corneal DegenerationCorneal EctasiaKeratoconusPellucid Marginal Corneal Degeneration

Phase 1

Safety and Effectiveness of the PXL-Platinum 330 System for CXL Using Riboflavin Solution

CompletedNCT04177082

Cornea Associates of TexasCorneal Degeneration, Corneal Ectasia, Keratoconus +1

Start: 2020-01-10End: 2022-05-05Updated: 2022-10-19

Safety and Effectiveness of the PXL-Platinum 330 System

Colorado Eye Consultants/Cornea Consultants of ColoradoCorneal Ectasia, Keratoconus, Pellucid Marginal Corneal Degeneration

Start: 2020-06-01End: 2023-06-30Target: 300Updated: 2022-01-25

Safety & Effectiveness of the PXL-Platinum 330 System for CXL Using Riboflavin Solution

CompletedNCT04667572

Cornea Associates of TexasCorneal Degeneration, Corneal Ectasia, Keratoconus +1

Start: 2021-02-01End: 2024-08-21Updated: 2025-02-11

Phase 2

Safety and Effectiveness of the PXL-Platinum 330 System for Corneal Cross-Linking in Eyes With Corneal Ectasia

RecruitingNCT04094090

Goodman Eye CenterCorneal Ectasia, Keratoconus, Pellucid Marginal Corneal Degeneration

Start: 2019-10-19End: 2029-10-19Target: 500Updated: 2025-10-17